Skip to content
Cash Flow Statement · TASI 8030

The Mediterranean and Gulf Insurance and Reinsurance Co.
Cash and cash equivalents at period end history.

Cash and cash equivalents at the end of each reporting period. Explore 18 reported observations from 2022 to 2026, with every value linked to its official evidence.

Coverage2022–202618 source-linked periods
Annual history3annual reporting periods
Interim history15quarterly or year-to-date periods
StatementCash Flow Statementas reported by the issuer
Annual series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2025IFRS 17Cash and cash equivalents at period end480.58M SAR
Cash and cash equivalents at period end0200M400M600M202320242025
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2026HISTORICALCash and cash equivalents at period end560.54M SAR

Reporting basis changed · 2023

Cash and cash equivalents at period end0200M400M600M800M20222023202420252026
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents at period end703.85M SAR

Reporting basis changed · 2023

Cash and cash equivalents at period end0200M400M600M800M20222023202420252026
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents at period end522.88M SAR

Reporting basis changed · 2023

Cash and cash equivalents at period end0200M400M600M800M1B20222023202420252026
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20262026-09-30522877Nine months ended 30 September 2026522.88M SARCash and cash equivalents, end of the periodOfficial p. 9 ↗Open statement →
H1 / Q2 20262026-06-30703,848Six months ended 30 June 2026703.85M SARCash and cash equivalents, end of periodOfficial p. 9 ↗Open statement →
Q1 20262026-03-31560,541Three months ended 31 March 2026 (Unaudited)560.54M SARCash and cash equivalents, end of the periodSigned copy p. 9 ↗Saudi Exchange filing ↗Open statement →
FY 20252025-12-31480,5802025-01-01 to 2025-12-31480.58M SARCash and cash equivalents, end of the yearOfficial p. 16 ↗Open statement →
9M / Q3 20252025-09-30916,964Nine months ended 30 September 2025 (Unaudited)916.96M SARCash and cash equivalents, end of the periodSigned copy p. 10 ↗Saudi Exchange filing ↗Open statement →
H1 / Q2 20252025-06-30687,477Six months ended 30 June 2025 (Unaudited)687.48M SARCash and cash equivalents, end of the periodSigned copy p. 10 ↗Saudi Exchange filing ↗Open statement →
Q1 20252025-03-31791,473Three months ended 31 March 2025 (Unaudited)791.47M SARCash and cash equivalents, end of the periodSigned copy p. 10 ↗Saudi Exchange filing ↗Open statement →
FY 20242024-12-31Comparative figures in an audited report486,0672024-01-01 to 2024-12-31486.07M SARCash and cash equivalents, end of the yearOfficial p. 16 ↗Open statement →
9M / Q3 20242024-09-30607,506Nine months ended 30 September 2024607.51M SARCash and cash equivalents, end of the periodOfficial p. 10 ↗Open statement →
H1 / Q2 20242024-06-30420457Six months ended 2024-06-30420.46M SARCash and cash equivalents at the end of the periodOfficial p. 10 ↗Open statement →
Q1 20242024-03-31660628Three months ended 2024-03-31660.63M SARCash and cash equivalents at the end of the periodOfficial p. 10 ↗Open statement →
FY 20232023-12-31440,5702023-01-01 to 2023-12-31440.57M SARCash and cash equivalents, end of the yearOfficial p. 15 ↗Open statement →
9M / Q3 20232023-09-30515222Nine months ended 2023-09-30515.22M SARCash and cash equivalents at the end of the periodOfficial p. 10 ↗Open statement →
H1 / Q2 20232023-06-30573022Six months ended 2023-06-30573.02M SARCash and cash equivalents at the end of the periodOfficial p. 10 ↗Open statement →
Q1 20232023-03-31373090Three months ended 2023-03-31373.09M SARCash and cash equivalents at the end of the periodOfficial p. 10 ↗Open statement →
9M / Q3 20222022-09-30460982Nine months ended 2022-09-30460.98M SARCash and cash equivalents at the end of the periodNote 6Official p. 9 ↗Open statement →
H1 / Q2 20222022-06-30518014Six months ended 2022-06-30518.01M SARCash and cash equivalents at the end of the periodNote 6Official p. 9 ↗Open statement →
Q1 20222022-03-31523497Three months ended 2022-03-31523.5M SARCash and cash equivalents at the end of the periodNote 6Official p. 9 ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

ميدغلف للتأمين — Cash and cash equivalents at period end

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.